Compare STTK & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | VMD |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.9M | 313.3M |
| IPO Year | 2020 | 2018 |
| Metric | STTK | VMD |
|---|---|---|
| Price | $6.18 | $8.63 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.60 | N/A |
| AVG Volume (30 Days) | ★ 617.5K | 318.8K |
| Earning Date | 03-05-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | 32.14 |
| EPS | N/A | ★ 0.37 |
| Revenue | $1,000,000.00 | ★ $270,280,000.00 |
| Revenue This Year | N/A | $24.27 |
| Revenue Next Year | N/A | $15.47 |
| P/E Ratio | ★ N/A | $24.96 |
| Revenue Growth | N/A | ★ 20.52 |
| 52 Week Low | $0.69 | $5.93 |
| 52 Week High | $6.27 | $10.06 |
| Indicator | STTK | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 73.59 | 46.66 |
| Support Level | $1.85 | $7.93 |
| Resistance Level | N/A | $8.94 |
| Average True Range (ATR) | 0.42 | 0.51 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 93.80 | 39.24 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.